How Vaccines Actually Work
The different technologies behind them
"Vaccine" isn't a single technology — several different approaches all achieve the same goal (training adaptive immunity) through different mechanisms, each with its own trade-offs.
The Main Approaches
Live-attenuated vaccines (e.g. MMR, chickenpox) use a weakened version of the actual pathogen, still capable of replicating but not of causing significant disease in a healthy immune system. These tend to produce strong, long-lasting immunity, often from a single dose or two, because they mimic natural infection closely.
Inactivated vaccines (e.g. most flu shots, hepatitis A) use a killed version of the pathogen. They can't replicate or cause the disease, but generally require booster doses since the immune response they generate tends to fade faster than with live-attenuated approaches.
Subunit and recombinant vaccines (e.g. the recombinant shingles vaccine, most HPV vaccines) use only a specific piece of the pathogen — a protein fragment — sufficient to train recognition without using any part of the pathogen capable of causing illness.
mRNA vaccines deliver genetic instructions that prompt your own cells to temporarily produce a harmless piece of the pathogen, which then trains the immune system the same way a subunit vaccine's protein fragment would — the mRNA itself degrades within days and does not alter your DNA.
Why the Technology Choice Matters
A comprehensive review of the field notes that most vaccines historically were developed and refined empirically, but newer platforms — recombinant subunit and mRNA approaches in particular — have allowed faster, more precisely targeted vaccine development, at some cost in the durability of the immune response compared to live-attenuated vaccines, which is part of why booster schedules differ so much by vaccine type[1]. None of these differences reflect one technology being inherently "safer" than another in a blanket sense — each has an established safety and efficacy profile specific to its own extensive trial and monitoring history.
Section takeaway
The specific technology behind a vaccine — live-attenuated, inactivated, subunit, or mRNA — explains why some need one dose and others need regular boosters, but all are working toward the same goal: training adaptive immune memory without requiring the actual disease first.